Health Care: Drugs

Repros Therapeutics Inc. (RPRX: NASDAQ)

$15.98 n/a | n/a%
04/17/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 15.98
52 Week High 29.79
52 Week Low 13.93
Avg. Daily Vol. (Mil) 0.39
Beta (3 year) -0.64
Share Related Items
Mkt Cap (Mil) 367.99
Shares Out (Mil) 23.03
Float (Mil) 14.09
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 21.30
Current Ratio 21.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 40.89K
Price/Book 4.88
Price/Cash Flow -13.40
Per Share Data
Earnings -1.33
Sales 0.00
Book Value 3.28
Cash Flow -1.19
Business Summary
Repros Therapeutics Inc. is development stage biopharmaceutical company focused on the development of oral small molecule drugs for major unmet medical needs in male and female health.
General Information
2408 Timberloch Place
Suite B-7
The Woodlands, TX 77380
www.reprosrx.com
Industry : Drugs
Sector: Health Care
Employees: 25
CEO: Joseph S. Podolski
Short Interest
Current Month (Mil) 2.66
Previous Month (Mil) 3.07
Short Interest Ratio (Days) 7.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -35.10
Return on Investments -36.80
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with RPRX

Latest RPRX Headlines from TheStreet

More Financial News for RPRX

Press Releases for RPRX

See All Press Releases

Partner Headlines for RPRX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter